Intercept Pharmaceuticals | ICPT - Umsatzkosten



Umsatzkosten Veränderung Datum
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amarin USD 26.05M 1.41M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Biogen USD 797.5M 302M 2026-03
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Incyte USD 121.18M 22.18M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12